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HEART FAILURE (HF) is the most frequent cause of death in industrial countries. The ultimate treatment for patients suffering from end-stage HF is the orthotopic heart transplantation (HTx). Increased mechanical loading and chronic neurohumoral stress are important triggers for the development of end-stage HF.
Both triggers are reduced by mechanical unloading after ventricular assist device (VAD) support (18) . Mechanical unloading of terminal failing myocardium by VAD was documented to reverse some gene expression changes that appear to be typical for the failing heart (1, 17, 22, 23, 26, 36, 37) . In addition there was evidence that mechanical unloading by VAD might stimulate regeneration of myocardial function, allowing the explantation of the device without transplantation (39) . However, it has been shown that, especially in some heart centers, sustainable recovery from terminal HF in VAD patients is found in a minor subgroup of patients only (7, 10, 29) . The reason for differences between the recovery rates in different heart centers is not exactly known at present but might depend on the weaning criteria.
The availability of microarray technology has led to the simultaneous analysis of thousands of genes in the myocardium and the identification of HF-associated transcriptome patterns (20) . However, it is not yet clear how changes of the transcriptome are functionally related to the HF phenotype.
Recently, some data from microarray experiments have been published for the transcriptome of the failing heart after VAD support (3, 5, 6, 16, 32) . However, all of these studies lack data from nonfailing control (NF) hearts, which appear to be essential for the comparison of what is achieved by mechanical unloading. Margulies et al. (30) have shown that mechanical unloading of the terminal failing heart leads to effects on the transcriptome patterns, which appear to reflect improvement, no effects of VAD support, or even worsening of HF-associated gene expression. However, in that paper only 11 paired samples from VAD patients could be analyzed. Thus, there are only limited data available on the relationship of the transcriptome in control hearts and changes found in terminal failing hearts during mechanical unloading.
Recently encouraging clinical data have been shown for long-term support of HF patients with continuous flow devices. Since little is known about the transcriptional effects of nonpulsatile VAD (npVAD) unloading and the increasing use of npVAD in clinical practice, we performed a subgroup analysis in matched patients supported by pulsatile VAD (pVAD) and npVAD. In addition, we analyzed the influence of the etiology on the VAD-related transcriptome, since initial reports revealed that the myocardium of patients with ischemic (ICM) or nonischemic cardiomyopathy (NICM) might reveal a different gene expression pattern, respectively (20, 25) . Therefore, we have analyzed paired myocardial samples from 30 VAD patients and compared our findings to the transcriptome of eight NF hearts. We provide data from the first whole genome chip comprising 38,500 characterized human genes and 54,000 probe sets.
MATERIALS AND METHODS
Patient population. We analyzed paired myocardial samples preand post-VAD support of 30 patients from our HTx program and eight nonfailing donor hearts, which could not be transplanted for technical reasons and were removed from the donor for cardiac valve grafting. All NF had no heart disease before death according to their medical records. Five were rejected from HTx because of a low output syndrome, and three were not accepted due to ECG anomalies, infection, or intoxication, respectively. Myocardial samples were collected and RNA isolated as described before (36) . Quantification of RNA was performed by a spectrophotometer at 260 nm. The mean supporting time was 256 days (Ϯ 214 days SD, range 4 -830 days), mean age was 51.3 yr (Ϯ 12.8 days). Eight out of 30 patients were supported by a continuous flow pump without pulsatility. The left ventricular end-diastolic diameter (LVEDD), age, duration of VAD support, cardiac index, and brain natriuretic peptide (BNP) plasma concentrations before ventricular assist device implantation (VAD-IP) were not significantly different between pVAD and npVAD. However, the ejection fraction of pVAD patients (24.4% Ϯ 6.7 SD) was significantly higher compared with those receiving npVAD (16.5% Ϯ 9.1 SD, P ϭ 0.02). For clinical data see Supplementary Table S1 . 1 Patients with ICM had a history of cardiac infarction and/or coronary stenosis, respectively, whereas patients with dilated cardiomyopathy (DCM) had dilated left ventricles without signs of coronary occlusion. Patients receiving LVAD as a bridge to transplant were tested for myocardial recovery. They revealed a significantly reduced LVEDD during VAD support, reflecting mechanical unloading of the failing ventricle (70 mm at VAD-IP vs. 55.5 mm 35 days after implantation, paired t-test: P Ͻ 0.01, n ϭ 12).
Array hybridization. Total RNA of myocardial samples was isolated and hybridized as previously published (41) . For analysis Affymetrix HG-U133 Plus 2.0 arrays of the same lot number were used (for details of the methods see Supplement).
Data analysis and quality control. Fluorescence intensities of scanned images (Agilent) were quantified, corrected for background noise, and normalized using the Affymetrix Microarray Analysis Suite (MAS 5.0) Software (Supplementary Fig. S1 ). All samples were reverse transcribed and hybridized in duplicate on the same devices. We used a global scaling approach for data comparison with the average hybridization intensity on each array scaled to a constant target value of 100. For reproducibility, these files have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession number GSE21610 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accϭGSE21610). For quality control, qRT-PCRs of selected genes were performed and compared with the corresponding microarray expression levels ( Supplementary Fig. S2 ).
Further statistical analysis was performed with Expressionist software (Genedata, Basel, Switzerland). We analyzed, prior to the t-tests, the rate of false positives using a balanced permutation approach (13) as a standard procedure within the Expressionist software. This approach compares the number of significantly regulated transcripts that are found in balanced permutated data with those found in the actual data set. The assumption is that the randomized data sets do not show any effect and all the significant transcripts identified from these random data are considered to be false positives and removed from further analysis. We restricted our analysis to a q-value of 0.05, which eliminates 95% of the false positives from our data set.
Functional data on the predicted secretory activity of proteins coded by identified transcripts (PIT) were done using several sources (for details see Supplementary Methods).
RESULTS

Regulation of HF-related genes by mechanical unloading.
We first compared the mRNA profile of eight nonfailing donor hearts (NF) with those genes, which were found in myocardial samples from end-stage HF patients before implantation of a VAD system (VAD-IP). We found in our cohort 352 probe sets regulated significantly (t-test, P Ͻ 0.001, fold change Ͼ1.6) between end-stage HF (VAD-IP) and NF control hearts ( fig. 1 ).
We secondly tested the samples taken from patients after being supported by a VAD (VAD-HTx) and found 510 probe sets significantly regulated compared with the NF with the same stringent parameters as above ( Fig. 1) . Supplementary  Fig. S3 shows a heat map of the top 70 regulated genes according to the coefficient of variation. Finally, we analyzed the number of probe sets regulated in patients during VAD support and found it to be remarkably low, namely 111 probe sets (see Supplementary Table S3 ). As depicted in Fig. 1 , the Venn diagram shows an overlap of 208 regulated probe sets, which are differentially expressed in both HF samples and donor hearts, whereas the number of probe sets regulated in the other combinations is comparable low.
We further analyzed the proportion of HF-related transcripts that were corrected by VAD support. We found, irrespective of the fold-change (FC) and after quality clipping, a maximum of 798 transcripts to be robustly regulated in HF (NF vs. VAD-IP, P Ͻ 0.001). Of these 266 were upregulated with an FC of at least 1.6, whereas 86 were downregulated (min. Ϫ1.6 fold). Mechanical unloading corrected (NF vs. VAD-HTx: P Ͼ 0.05) 1 The online version of this article contains supplemental material. A fold-change (FC) threshold (FC Ն 1.6) and a P-value cut-off (P Յ 0.001) have been applied to filter only the most relevant probe sets. Probe sets with questionable quality have been excluded from the analysis. The 1st test revealed 352 differentially expressed probe sets between nonfailing control (NF) and ventricular assist device implantation (VAD-IP) samples (red circle), the 2nd showed 510 items between NF and VAD-heart transplantation (HTx) (blue circle), whereas only 111 probe sets between VAD-IP and VAD-HTx (green circle) were found (Supplementary Table S3 ). the gene expression of seven (ϭ 2.6%) transcripts upregulated in HF and six (ϭ 6.9%) of the downregulated ones (Table 1) .
Clustering of transcriptome data. We were able to separate NF from pre-and post-VAD samples in an unsupervised manner with hierarchical clustering (HC) ( Fig. 2A) and principal component analysis (PCA) (Fig. 2B) . Furthermore, distinction between VAD-IP and VAD-HTx samples has been achieved by unsupervised PCA (Fig. 2B ), using components 4 -6, indicating that the unloaded failing heart does not reveal a transcriptome pattern that moves toward NF control samples. However, separation of the subgroups was only achieved in higher components of the PCA, revealing that only a minor fraction of the overall variance was relevant for this distinction.
Comparison of NF, VAD-IP, and VAD-HTx samples regarding cardiac hypertrophy. We compared our expression patterns to eight NF donor heart samples with an emphasis on hypertrophy-relevant pathways and known marker genes. Performing three t-tests (P Ͻ 0.05) with 44 hypertrophy-relevant marker genes (according to MetaCore database, GeneGo, St. Joseph, MO) on each possible pair of our sample groups, we found Ͼ60% significantly regulated in the dataset. Between NF and VAD-IP, 27 marker genes were detected, whereas between NF and VAD-HTx only 16 were still present, indicating a partial normalization of the expression pattern that may be related to the decreasing cellular hypertrophy in VAD supported myocardium.
Analysis pulsatile and nonpulsatile mechanical unloading. Since the mode of unloading between pVAD and npVAD is different, we analyzed the transcriptome on differences, which might be due to the implanted VAD system. For the identification of more relevant transcripts we performed a subgroup analysis with eight pVAD-vs. eight npVAD-supported samples. We matched the VAD patients according to their sex and etiology. The age of the patients was not significantly different between the subgroups. As pulsatile device subjects we included only Novacor-supported patients (see Supplementary  Table S1 for the matched individuals). We identified 282 pVAD-and 86 npVAD-specific transcripts to be differentially regulated between these groups (P Ͻ 0.01, see Supplementary  Fig. S4 for the Venn diagram). These transcripts were used to separate pVAD and npVAD in the whole cohort by clustering algorithms. However, using the genes identified in the matched cohort, we were not able to separate the patients of the whole study population according to their VAD-drive mode (Fig. 3, A  and B) , indicating that pVAD-and npVAD-supported myocardium does not reveal a robust drive mode-specific gene expression pattern on the mRNA level.
Analysis of the HF etiology (DCM and ICM).
Comparing the etiology of the study cohort ICM vs. DCM revealed fourfold more differently expressed genes (t-test, P Ͻ 0.01) in pre-vs. post-VAD within the ICM group compared with the DCM group. Supporting this finding, the t-tests between NF and VAD-HTx of ICM patients identified 406 differentially expressed genes (P Ͻ 0.001), whereas NF and VAD-HTx of DCM patients revealed 1,075 probe sets. Thus, it appears that, with respect to the number of differentially expressed transcripts, ICM patients differ less from NF than DCM patients after mechanical unloading.
On the other hand, if one takes natriuretic peptide precursor (NPP) A and NPPB expression levels as markers for the effectiveness of mechanical unloading (24, 34) , VAD support more effectively reduces the NPPA and NPPB mRNA in DCM compared with the ICM patients.
We further checked the identified transcripts for their secretion probability and found 8 ICM-and 149 DCM-specific genes to be putative biomarkers (Supplementary Table S2 ). Among these, NPPA was identified to be especially upregulated in the DCM cohort with the highest FC of 11.9, whereas NPPB expression and BNP plasma levels did not show significant differences between the ICM and DCM subgroups. The second most discriminating gene found was hemoglobin-␣-1 with an FC of 7.5.
We further analyzed the influence of the etiology and compared our etiology-specific transcripts with those of previous publications. The etiology-specific transcripts of our study were mapped on the specific gene set identified in the metaanalysis of Kuner et al. (25) , evaluating 279 HF samples retrospectively. We found that only 14 transcripts of our study were present in that list. We also compared the gene list of Kittleson et al. (21) with the etiology-specific gene set of Kuner et al. (25) and found that only two transcripts were HF, heart failure; NF, nonfailing control; VAD-IP, ventricular assist device implantation; HTx, heart transplantation.
Fig. 2. Unsupervised data analysis allows clear distinction between the NF group (green) and the disease groups (red and blue). However, it was not possible to distinguish between VAD-IP and VAD-HTx disease groups by means of an unsupervised hierarchical clustering (HC) analysis (A). Despite this, we obtained good differentiation of the groups by performing an unsupervised principal component analysis (PCA, B).
It should be noted, however, that the decisive components (4, 5, and 6) represent only a small fraction of the overall variance within the dataset, which is mainly contained within the first 3 components of the PCA. However, components 1-3 of the PCA did also not allow differentiation of the disease groups as was shown for the HC. Both clustering methods reveal that an unsupervised analysis does not lead to robust device-or unloading-specific expression patterns.
common to both lists, supporting previous findings that it is challenging to identify etiology-specific gene sets using data from different sources (25, 42) . Analysis of age and sex influences. We checked the influence of age and sex on the identification of the HF transcriptome in our study. The age of the NF samples is significantly different from HF samples used in this study, and we included two females among the NF and HF samples, respectively.
We found a number of transcripts that might reveal age-dependent expression. However, none of the genes that discriminated best between age and sex (see heat map in Supplementary Fig. S3 ) could be associated with HF. In other words the differences between failing and nonfailing samples were not influenced by transcripts that might be age dependent.
In addition we compared our HF-related genes at the time of VAD implantation and transplantation with published data (19) . There was a striking correlation of transcripts identified in our cohort with those of previously published data (21), indicating that the identification of HF-related transcripts was not influenced by age differences in the study cohort (Supplementary Fig. S5 ). In another subgroup analysis we identified transcripts that appear to be sex related. A number of these transcripts are identical to those identified by Fermin et al. (11) . However, we excluded these probe sets from further analysis, since they were mainly coded by the heterosomes. We also found that the sex-specific transcripts were not related to the HF-related genes identified in this study and therefore do not influence the analysis of our cohort.
Analysis of support time.
We examined the influence of VAD support time in our patients. For this analysis the patient pool was split into four groups depending on the time of VAD support (Ͻ100, 100 -199, 200 -299, and Ն300 days, respectively). Within each group correlation analysis was performed, and the number of changing transcripts within each time period compared (Table 2) . We found the number of correlated genes decreased with increasing support time since most changes of gene expression were induced immediately after device implantation. However, we also found that a considerable number of transcripts were regulated after a support time of Ͼ300 days ( Table 2 ). None of the identified genes was found in more than one of the four groups.
DISCUSSION
Mechanical and humoral stress is regarded to be of major relevance for the progress of HF. Mechanical unloading of the failing heart reduces considerably these influences, resulting in reverse remodeling of the heart. Surprisingly, in our study we found that mechanical unloading has a minor influence on the molecular phenotype of the terminal failing myocardium since cluster algorithms failed to separate individual VAD-IP and VAD-HTx samples, whereas both were distinct from NF controls. Nevertheless, in previous studies (3, 5, 6, 16, 30, 32) a number of transcripts were identified as being regulated during VAD support. Only one study compared nonfailing control myocardium with the cardiac transcriptome of VAD patients (30) . However, in that paper only 11 paired samples were available, a less complete microarray was used, and the device types were not specified. There has been considerable progress in the development of devices for the support of the terminally failing heart; in particular npVAD is seeing increasing clinical use. However, up to now little is known of the influence of nonpulsatile, and thus unphysiological, unloading by continuous flow VAD (12) on the failing heart. Therefore, in our study, using a whole genome array, we investigated 30 paired samples from terminal HF patients supported by pulsatile and nonpulsatile devices and compared our findings to eight nonfailing control samples. By adding nonfailing references we considerably increased the amount of information gathered from the experiments: One of the most interesting findings (see Fig. 1 ), related to the inclusion of control myocardium in our study, is that we found 208 differentially expressed transcripts related to HF (VAD-IP and VAD-HTx vs. NF), whereas mechanical unloading induced gene expression changes in only 42 transcripts (VAD-IP vs. VAD-HTx). Consequently NF control samples are essential for the assessment of what is achieved by mechanical unloading.
For the overall analysis of gene expression we chose stringent conditions (P Ͻ 0.001, FC Ͼ 1.6) to receive a robust molecular HF pattern in our cohort. We found that the overall molecular phenotype of the unloaded failing heart can be separated from terminal HF by cluster algorithms (Fig. 2) . However, the VAD-supported myocardial samples investigated in our study revealed an HF-related molecular phenotype that is distinct from NF control samples (Fig. 2B) . Thus, we did not find evidence for a correction or exacerbation (30) on the transcriptome level but rather an unloading-specific HF phenotype in VAD-supported myocardium when the whole transcriptome pattern was used. We speculate that epigenetic mechanisms might be responsible for an HF-related arrest of the gene expression pattern. However, it remains to be investigated whether i.e., methylation of the genomic DNA is different in HF and control myocardium in humans.
Nevertheless, in previous reports on the molecular effects of mechanical circulatory support (MCS) on the failing myocardium some functional improvement was reported i.e., for the force frequency relationship, SR-Ca 2ϩ -ATPase expression (2, 17, 24) and activity (37) and the response to ␤-adrenergic agonists (9, 38) . However, we and others (8) found also that in MCS-supported myocardium HF-related changes of the ultrastructure (35) and the extracellular matrix (ECM) (23, 27, 28, 31) were not significantly improved by VAD unloading. Moreover, we found that the protein of the ␤1-adrenergic receptor but not its mRNA is upregulated during MCS (38) , reflecting a specific HF-related phenotype. In addition clinical data on recovery during MCS do not support a general recovery process. Thus, our transcriptome data are in accordance with some previously published laboratory and clinical findings.
Meta-analysis of our findings with previously published data. Since there is discrepancy on the degree of clinical recovery (4, 10, 14, 29, 39) in MCS patients we compared our chip data in a meta-analysis with data published previously by other groups. We compared the published (16) gene list with the corresponding probe sets in our data set (Fig. 4A) . The transcripts regulated by MCS in our cohort are highly reproducible compared with previously published data of nonrecovery patients transplanted after VAD support.
However, despite the high reproducibility of the previous publication, we hardly see any of the findings in our present dataset, which were identified in the myocardium of patients developing cardiac recovery under MCS (15) . Thus, the gene expression changes during unloading by MCS are significantly different between the cohort revealing recovery and those that did not (Fig. 4B) . Since the published data of that paper (15) are only available as FC, it is not possible to test the molecular differences at the time of device insertion.
pVAD vs. npVAD. Since little is known on the effects of nonphysiological mechanical unloading by continuous-flow VAD, in our dataset we compared differentially regulated transcripts identified after pVAD or npVAD support. The overall gene expression pattern was not significantly different between pVAD-and npVAD-supported patients using PCA analysis (Fig. 5) . To compare a more homogenous subset, we conducted a subgroup analysis (33) with samples from Novacor-supported patients and those from npVAD-supported individuals. We identified a number of transcripts differentially regulated in each group after MCS (Supplementary Fig. S4 ). However, PCA and HC with the transcripts identified in the matched cohort failed to separate pVAD and npVAD of the whole study cohort (Fig. 3, A and B) . Thus, pVAD and npVAD support does not provide evidence for a robust, pump systemspecific transcriptome pattern of the myocardium.
ECM genes. We performed a pathway analysis for genes related to ECM remodeling. Although ECM-related genes Fig. 5 . Unsupervised PCA of pulsatile (red) and nonpulsatile pump (blue) modes did not lead to distinct clusters.
were found to be upregulated in HF, like TIMP2, TIMP3, vitronectin, laminin1, or MMP2, we did not find evidence for upregulation of the most abundant ECM proteins collagen I and III (40) , comprising fibrotic remodeling of the failing myocardium. Surprisingly, we and others (20, 21) could therefore not find evidence for cardiac fibrotic remodeling by transcriptome analysis. During mechanical unloading we found downregulation of TIMP1 and collagen III but no regulation of the HF-related ECM genes mentioned above.
Limitations of the study. The study population was recruited from a single center and might not necessarily be comparable to other centers. The VAD patients analyzed did not reveal cardiac regeneration under MCS. Therefore, the molecular pattern of the VAD-HTx samples does not represent a phenotype of the recovered heart but the molecular fingerprint of bridge-to-transplant patients. Nevertheless, gene expression changes identified in this study reveal a comprehensive array of the HF-related genes that can be influenced by MCS.
